Rafael Alfonso

Lead Evidence Analytics & Innovation

GSK

Dr. Alfonso is an energetic physician, researcher and innovator determined to improve decision-making in healthcare. He graduated from Medical School from Universidad del Rosario in Colombia, his native country; holds a Master in Sciences in Pharmacoepidemiology from the Universidad Autonoma de Barcelona in Spain, and a PhD from the Pharmaceutical Outcomes Research and Policy Program (PORPP) at the University of Washington (UW). He currently leads the Analytics and Innovation group in Value Evidence and Outcomes in R&D at GSK and maintains his affiliation as Faculty in the Department of Surgery at the University of Washington.

Before joining GSK, he was the Scientific Director of the Surgical Outcomes Research Center (SORCE) at the University of Washington in Seattle and the Comparative Effectiveness Research and Translation Network (CERTAIN – www.becertain.org), leading the development of a Collaborative for Healthcare research in behaviOral economIcs and deCision sciEnceS (CHOICES).

His research activities have focused in the development of innovative economic and disease models in chronic conditions such as diabetes, obesity, rheumatoid arthritis, and endocrine tumors and incorporating novel methods for Comparative Effectiveness Research and behavioral economics to improve decision making in the health care system, across different settings and conditions.

He has been invited to work on projects to advice governments, pharmaceutical companies, and private insurers in the development and improvement of Health Technology Assessment. He also currently serves as Advisor in the Prevention, Diagnosis and Treatment Options for PCORI, and served as Advisor for the Pan American Health Organization (PAHO-Bio PANDRH working group-2010) for the Regulation of Biologics and Biosimilars. Dr. Alfonso is an active member of the International Society for Pharmacoeconomics and Outcomes research (ISPOR), more recently as Chair of the Advisory Board for the Latin American Consortium (2012-2014). Additionally, he was the Founder and Scientific Director of RANDOM Foundation, a non-profit organization in Colombia dedicated to promote and improve Clinical and Outcomes Research in Latin America.